Raymond James Financial Services Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Raymond James Financial Services Advisors’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$898K	Sell	21,427 -956	-4%	-$39.7K	﹤0.01%	2234
2024 Q2	$914K	Buy	22,383 +91	+0.4%	+$3.62K	﹤0.01%	2143
2024 Q1	$924K	Buy	22,292 +87	+0.4%	+$3.64K	﹤0.01%	2118
2023 Q4	$898K	Sell	22,205 -2,526	-10%	-$96.5K	﹤0.01%	2046
2023 Q3	$968K	Sell	24,731 -1,798	-7%	-$71.6K	﹤0.01%	1929
2023 Q2	$1.08M	Buy	26,529 +18	+0.1%	+$741	﹤0.01%	1882
2023 Q1	$1.11M	Buy	26,511 +1,046	+4%	+$44K	﹤0.01%	1841
2022 Q4	$1.11M	Sell	25,465 -603	-2%	-$25.6K	﹤0.01%	1772
2022 Q3	$1.01M	Buy	26,068 +326	+1%	+$13.9K	﹤0.01%	1801
2022 Q2	$1.09M	Sell	25,742 -1,935	-7%	-$84K	﹤0.01%	1780
2022 Q1	$1.26M	Buy	27,677 +6,098	+28%	+$270K	﹤0.01%	1795
2021 Q4	$1.05M	Buy	21,579 +1,524	+8%	+$72.1K	﹤0.01%	1960
2021 Q3	$956K	Sell	20,055 -556	-3%	-$27.1K	﹤0.01%	1990
2021 Q2	$1M	Sell	20,611 -3,062	-13%	-$146K	﹤0.01%	1942
2021 Q1	$1.09M	Sell	23,673 -2,135	-8%	-$101K	﹤0.01%	1792
2020 Q4	$1.23M	Sell	25,808 -6,775	-21%	-$307K	﹤0.01%	1580
2020 Q3	$1.4M	Sell	32,583 -547	-2%	-$23.4K	﹤0.01%	1344
2020 Q2	$1.35M	Sell	33,130 -4,558	-12%	-$184K	﹤0.01%	1317
2020 Q1	$1.36M	Buy	37,688 +2,591	+7%	+$103K	0.01%	1064
2019 Q4	$1.49M	Buy	35,097 +3,591	+11%	+$142K	﹤0.01%	1326
2019 Q3	$1.21M	Buy	31,506 +1,426	+5%	+$54.9K	﹤0.01%	1361
2019 Q2	$1.17M	Buy	30,080 +9,591	+47%	+$365K	﹤0.01%	1408
2019 Q1	$815K	Buy	20,489 +8,213	+67%	+$325K	﹤0.01%	1572
2018 Q4	$447K	Buy	12,276 +2,584	+27%	+$102K	﹤0.01%	1741
2018 Q3	$412K	Buy	9,692 +572	+6%	+$23.2K	﹤0.01%	2063
2018 Q2	$352K	Buy	9,120 +1,580	+21%	+$57.3K	﹤0.01%	2121
2018 Q1	$264K	Buy	+7,540	New	+$268K	﹤0.01%	2099

Other funds holding BME

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.21B AUM 19.13% 1-Year Est. Return

Raymond James Financial Services Advisors's BME Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its BlackRock Health Sciences Trust (BME) stake by 4.3% in Q3 2024, selling an estimated $39.7K and leaving 21,427 shares worth $898K. The position accounts for ﹤0.01% of the portfolio, ranked #2234.

Raymond James Financial Services Advisors first reported a position in BME in Q1 2018 and has held it in 27 quarters since. The position peaked at $1.49M in Q4 2019. 73 funds tracked by Wall St. Rank hold BME as of Q3 2024.

Raymond James Financial Services Advisors held 21,427 shares of BlackRock Health Sciences Trust worth $898K as of Q3 2024.
Raymond James Financial Services Advisors sold 956 BlackRock Health Sciences Trust shares in Q3 2024, an estimated $39.7K.
BlackRock Health Sciences Trust made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2234 holding.
Raymond James Financial Services Advisors first reported a position in BlackRock Health Sciences Trust in Q1 2018 and has held it in 27 quarters since.
Raymond James Financial Services Advisors's BlackRock Health Sciences Trust position peaked at $1.49M in Q4 2019.
73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.